The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal ...

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based ...

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata ...

Beate Mueller-Tiemann is chief technology officer at Cytiva. With a passion for science and an ‘eternal technology optimist’, ...